We work across a range of disciplines and with a diverse set of stakeholders.
UK EU Life Sciences Transition ProgrammeThe ABPI is working with the BIA to engage the broad life sciences industry to outline the work needed to create a world-leading life sciences environment in the UK outside of the EU.
Industrial StrategyTo maximise the economic benefits to the UK, an industrial strategy for life sciences will need to consider the whole life-cycle for medicines, including how medicines are used by the NHS, as an integral part of creating a world-class offer for biopharmaceutical investment and jobs.
ABPI blogsOpinion and key information from around the organisation.
Biological Medicines Access Group (BMAG)The ABPI Biological Medicines Access Group (BMAG) aims to raise awareness and understanding of key considerations related to biological medicines, including biosimilar medicines.
Cancer Drugs Fund (CDF)The Fund was initially introduced in 2010 to enhance patient access to cancer medicines through the NHS and was amended and relaunched in July 2016 in order to allow more patients to access innovative new treatments.
Careers in the pharmaceutical industryThe pharmaceutical industry in the UK offers a wide variety of opportunities.
CommercialInformation about our work to ensure that the value of medicines is properly assessed and that the right patient receives the right medicine at the right time.
Disclosure of payments to individual healthcare professionalsThe ABPI disclosure of payments pages deliver information and updates on our plans to make publicly available details of certain payments to healthcare professionals (HCPs) in the UK.
This section provides background on the 2011 Directive alongside an overview of what is required for the implementation of the Delegated Regulation (EU 2016/161) in the UK by 2019.
Medicines Manufacturing Industry Partnership (MMIP)Medicines Manufacturing Industry Partnership (MMIP) represents the voice of medicines manufacturers in the UK.
NICE Implementation Collaborative (NIC)The NIC runs exemplar projects understanding barriers and identifying solutions to overcome persistent problems that prevent change and implementation of NICE guidance.
Patient Organisation ForumThe forum aims to identify areas of mutual interest and promote shared understanding.
Policy and parliamentary workWe engage with Government and regulators on specific issues of interest to the pharmaceutical industry.
Publications libraryKey publications from across the organisation.
ReputationWe are working in partnership with many key stakeholders to ensure that we dispel old myths about how we work and break down barriers to partnership working.
Research, medical and innovationWe support our members and provide information to government departments and members of the public throughout all phases of medicine development.
Resources for schoolsFind out about the resources we offer for school students and teachers.
StrategyInformation about our strategy and operating plans.
Vaccines GroupThe ABPI Vaccine Group is committed to advocating on behalf of the industry on all aspects of vaccination and the benefits it brings to the health of our nation.
Value and accessFind out about our work in the areas of value and access.